Mangrove Partners’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-36,413
| Closed | -$8.89M | – | 124 |
|
|
2020
Q3 | $8.89M | Buy |
36,413
+4,818
| +15% | +$1.18M | 1.12% | 26 |
|
|
2020
Q2 | $9.1M | Buy |
31,595
+8,801
| +39% | +$2.53M | 2.22% | 14 |
|
|
2020
Q1 | $4.65M | Sell |
22,794
-5,449
| -19% | -$1.11M | 0.64% | 28 |
|
|
2019
Q4 | $12.6M | Hold |
28,243
| – | – | 1.85% | 17 |
|
|
2019
Q3 | $8.69M | Hold |
28,243
| – | – | 1.05% | 23 |
|
|
2019
Q2 | $8.98M | Buy |
28,243
+10,000
| +55% | +$3.18M | 1.02% | 25 |
|
|
2019
Q1 | $7.65M | Hold |
18,243
| – | – | 1.02% | 24 |
|
|
2018
Q4 | $5.56M | Buy |
+18,243
| New | +$5.56M | 0.74% | 28 |
|
|
2015
Q2 | – | Sell |
-2,222
| Closed | -$18.9M | – | 44 |
|
|
2015
Q1 | $18.9M | Buy |
+2,222
| New | +$18.9M | 4.57% | 5 |
|